54 related articles for article (PubMed ID: 7589715)
1. Overexpression of p53 and MDM2 proteins in cervical neoplasia.
Lukás Z; Vojtĕsek B; Anton M; Picksley SM; Kubálek V
Folia Biol (Praha); 1995; 41(3-4):197-9. PubMed ID: 7589715
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia.
Dellas A; Schultheiss E; Almendral AC; Gudat F; Oberholzer M; Feichter G; Moch H; Torhorst J
Int J Cancer; 1997 Aug; 74(4):421-5. PubMed ID: 9291432
[TBL] [Abstract][Full Text] [Related]
3. p53 and MDM2 expression in oral squamous cell carcinoma.
Matsumura T; Yoshihama Y; Kimura T; Shintani S; Alcalde RE
Oncology; 1996; 53(4):308-12. PubMed ID: 8692535
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of mdm2 and p21WAF1 in invasive cervical cancer: correlation with p53 protein and high risk HPV infection.
Troncone G; Martinez JC; Palombini L; De Rosa G; Mugica C; Rodriguez JA; Zeppa P; Di Vizio D; Lucariello A; Piris MA
J Clin Pathol; 1998 Oct; 51(10):754-60. PubMed ID: 10023338
[TBL] [Abstract][Full Text] [Related]
5. In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastases.
Emanuels AG; Koudstaal J; Burger MP; Hollema H
Br J Cancer; 1999 Apr; 80(1-2):38-43. PubMed ID: 10389975
[TBL] [Abstract][Full Text] [Related]
6. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions.
Dimitrakakis C; Kymionis G; Diakomanolis E; Papaspyrou I; Rodolakis A; Arzimanoglou I; Leandros E; Michalas S
Gynecol Oncol; 2000 Apr; 77(1):129-36. PubMed ID: 10739702
[TBL] [Abstract][Full Text] [Related]
7. High prognostic significance of Mdm2/p53 co-overexpression in soft tissue sarcomas of the extremities.
Würl P; Meye A; Schmidt H; Lautenschläger C; Kalthoff H; Rath FW; Taubert H
Oncogene; 1998 Mar; 16(9):1183-5. PubMed ID: 9528860
[TBL] [Abstract][Full Text] [Related]
8. Detection of p53 and MDM2 protein expression in head and neck carcinogenesis.
Girod SC; Cesarz D; Fischer U; Krueger GR
Anticancer Res; 1995; 15(4):1453-7. PubMed ID: 7654034
[TBL] [Abstract][Full Text] [Related]
9. [TP53 gene aberrations in chondromatous neoplasms: correlation with immunohistochemical p53 accumulation and MDM2 expression].
Blasenbreu S; Baretton GB; Bender C; Haas CJ; Diebold J; Löhrs U
Verh Dtsch Ges Pathol; 1998; 82():284-9. PubMed ID: 10095448
[TBL] [Abstract][Full Text] [Related]
10. Selective compartmentalization of different mdm2 proteins within the nucleus.
Maxwell SA
Anticancer Res; 1994; 14(6B):2541-7. PubMed ID: 7872679
[TBL] [Abstract][Full Text] [Related]
11. Strong correlation of basement membrane degradation with p53 inactivation and/or MDM2 overexpression in superficial urothelial carcinomas.
Ozdemir E; Kakehi Y; Okuno H; Habuchi T; Okada Y; Yoshida O
J Urol; 1997 Jul; 158(1):206-11. PubMed ID: 9186361
[TBL] [Abstract][Full Text] [Related]
12. p53 and MDM2 protein expression in squamous cell carcinoma and neighboring dysplasia from the upper aerodigestive tract.
Ambrosch P; Ruschenburg I
Anticancer Res; 2000; 20(5A):3151-5. PubMed ID: 11062736
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1, p53, mdm2, and Ki67 protein expression in preneoplastic lesions of the larynx.
Capaccio P; Carboni N; Pignataro L; Scotti A; Ottaviani F; Pruneri G
J Chemother; 1997 Apr; 9(2):113-4. PubMed ID: 9176749
[No Abstract] [Full Text] [Related]
14. MDM2 expression in areca quid chewing-associated oral squamous cell carcinomas in Taiwan.
Huang JS; Ho TJ; Chiang CP; Kok SH; Kuo YS; Kuo MY
J Oral Pathol Med; 2001 Jan; 30(1):53-8. PubMed ID: 11140901
[TBL] [Abstract][Full Text] [Related]
15. Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue.
Porter PL; Gown AM; Kramp SG; Coltrera MD
Am J Pathol; 1992 Jan; 140(1):145-53. PubMed ID: 1731521
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the immunoreactivity of three anti-p53 antibodies and estimation of the relations between p53 status and MDM2 protein expression in ovarian carcinomas.
Harlozińska A; Bar J; Montenarh M
Anticancer Res; 2000; 20(2A):1049-56. PubMed ID: 10810396
[TBL] [Abstract][Full Text] [Related]
17. [Role of functional inactivation of p53 from MDM2 overexpression in hepatocarcinogenesis].
Luo YL; Cheng RX; Feng DY
Hunan Yi Ke Da Xue Xue Bao; 2001 Feb; 26(1):13-6. PubMed ID: 12536604
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of MDM2, p53, and NCAM proteins in human radiation-induced skin ulcers.
Zhao P; Wang D; Gao Y; Yang Z; Li X
J Environ Pathol Toxicol Oncol; 1998; 17(2):125-7. PubMed ID: 9546748
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of p53, mdm2, and bcl-2 proteins in renal cell carcinoma.
Uchida T; Gao JP; Wang C; Jiang SX; Muramoto M; Satoh T; Minei S; Shimura S; Irie A; Kameya T; Baba S
Urology; 2002 Apr; 59(4):615-20. PubMed ID: 11927338
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of Mdm2 and p53 in penile verrucous carcinoma.
Ouban A; Dellis J; Salup R; Morgan M
Ann Clin Lab Sci; 2003; 33(1):101-6. PubMed ID: 12661905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]